These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6816391)

  • 41. Contribution of noradrenergic neurons to the regulation of dopaminergic (D1) receptor denervation supersensitivity in rat prefrontal cortex.
    Tassin JP; Studler JM; Hervé D; Blanc G; Glowinski J
    J Neurochem; 1986 Jan; 46(1):243-8. PubMed ID: 3079614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regenerative critical periods for locus coeruleus in postnatal rat pups following intracisternal 6-hydroxydopamine: a model of noradrenergic development.
    Schmidt RH; Kasik SA; Bhatnagar RK
    Brain Res; 1980 Jun; 191(1):173-90. PubMed ID: 7378749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of 6-hydroxydopamine-induced norepinephrine depletion on cerebellar development.
    Lovell KL
    Dev Neurosci; 1982; 5(4):359-68. PubMed ID: 6814890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extension and regeneration of corticospinal axons after early spinal injury and the maintenance of corticospinal topography.
    Bates CA; Stelzner DJ
    Exp Neurol; 1993 Sep; 123(1):106-17. PubMed ID: 8405271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A possible role for spinal noradrenaline in the mechanisms of 6-hydroxydopamine against pentylenetetrazol induced convulsions in rats.
    Abed WT
    Life Sci; 1988; 43(22):1831-6. PubMed ID: 3143878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired growth of the cerebral cortex of rats treated neonatally with 6-hydroxydopamine under different environmental conditions.
    Brenner E; Mirmiran M; Uylings HB; Van der Gugten J
    Neurosci Lett; 1983 Nov; 42(1):13-7. PubMed ID: 6318162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific gravity of brain tissue during maturation.
    Johansson BB; Linder LE
    Acta Neurol Scand; 1982 Nov; 66(5):575-81. PubMed ID: 6816004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective neurotoxic lesions of descending serotonergic and noradrenergic pathways in the rat.
    Berge OG; Fasmer OB; Tveiten L; Hole K
    J Neurochem; 1985 Apr; 44(4):1156-61. PubMed ID: 3919157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of dopamine neurons in the regulation of beta-adrenergic receptor sensitivity in rat prefrontal cortex.
    Hervé D; Trovero F; Blanc G; Vezina P; Glowinski J; Tassin JP
    J Neurochem; 1990 Jun; 54(6):1864-9. PubMed ID: 2159976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasopressin and noradrenaline coexistence in the rat locus ceruleus: differential decreases of their levels in distant brain areas after thermal and neurotoxic lesions.
    Caffé AR; van Leeuwen FW; Buijs RM; van der Gugten J
    Brain Res; 1988 Sep; 459(2):386-90. PubMed ID: 3140998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alterations of norepinephrine metabolism in rat locus coeruleus neurons in response to axonal injury.
    Levin BE
    Brain Res; 1983 Dec; 289(1-2):205-14. PubMed ID: 6198035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the possible involvement of sulphomucopolysaccharides in the storage of catecholamines within the central nervous system.
    Pycock C; Blaschke E; Bergqvist U; Uvnäs B
    Acta Physiol Scand; 1975 Dec; 95(4):373-82. PubMed ID: 128986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Noradrenaline neuron plasticity in developing rat brain: effects of neonatal 6-hydroxydopamine demonstrated by dopamine-beta-hydroxylase immunocytochemistry.
    Gustafson EL; Moore RY
    Brain Res; 1987 Dec; 465(1-2):143-55. PubMed ID: 3125948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regenerating and sprouting axons differ in their requirements for growth after injury.
    Bernstein-Goral H; Diener PS; Bregman BS
    Exp Neurol; 1997 Nov; 148(1):51-72. PubMed ID: 9398450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effect of various 6-hydroxydopa treatments on the development of central and peripheral noradrenergic neurons.
    Jaim-Etcheverry G; Zieher LM
    Eur J Pharmacol; 1977 Sep; 45(2):105-16. PubMed ID: 902684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of noradrenaline and 5-hydroxytryptamine depletion on locomotion in the cat.
    Steeves JD; Schmidt BJ; Skovgaard BJ; Jordan LM
    Brain Res; 1980 Mar; 185(2):349-62. PubMed ID: 7357433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of neonatal sympathectomy with 6-hydroxydopamine or guanethidine on survival of neurons in the intermediolateral cell column of rat spinal cord.
    Krukoff TL; Fernandez MC; Vincent DH
    J Auton Nerv Syst; 1990 Nov; 31(2):119-26. PubMed ID: 2127052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Density of the dopamine innervation in rat cerebral cortex after neonatal 6-hydroxydopamine or adult stage DSP-4 noradrenaline denervations: a quantitative radioautographic study.
    Berger B; Doucet G; Descarries L
    Brain Res; 1988 Feb; 441(1-2):260-8. PubMed ID: 3129129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Descending noradrenergic pathways involved in the A5 depressor response.
    Loewy AD; Marson L; Parkinson D; Perry MA; Sawyer WB
    Brain Res; 1986 Oct; 386(1-2):313-24. PubMed ID: 3096495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: relationship between receptor occupancy and response and effects of denervation.
    Kendall DA; Brown E; Nahorski SR
    Eur J Pharmacol; 1985 Aug; 114(1):41-52. PubMed ID: 2995075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.